Does mutation of transforming growth factor-β type II receptor gene play an important role in colorectal polyps?

被引:11
|
作者
Togo, G
Okamoto, M
Shiratori, Y
Yamaji, H
Kato, J
Matsumura, M
Sano, T
Motojima, T
Omata, M
机构
[1] Univ Tokyo, Fac Med, Dept Gastroenterol, Bunkyo Ku, Tokyo 1130033, Japan
[2] Asahi Life Fdn, Inst Adult Dis, Div Gastroenterol, Tokyo, Japan
[3] Motojima Gen Hosp, Div Pathol, Gunma, Japan
[4] Motojima Gen Hosp, Div Surg, Gunma, Japan
关键词
colorectal polyp; microsatellite instability; hereditary nonpolyposis colorectal cancer; mismatch repair gene; transforming growth factor-beta type II receptor;
D O I
10.1023/A:1018834404570
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mutations in the transforming growth factor-beta type TT receptor (RII) gene that remain uncorrected due to mutation and inactivation of mismatch repair genes play an important role in hereditary nonpolyposis colorectal cancer (HNPCC) and in a subset of sporadic colorectal cancers. Some colorectal cancers develop from colorectal polyps. To elucidate the role of the RII gene in the generation of colorectal polyps, we analyzed 137 colorectal polyps from 100 patients for RII mutations and microsatellite instability (MSI). MSI was detected in three of 36 polyps from 25 patients. For one of these three polyps, the mobilities of the PCR products between polyp and nonpolyp tissues was different for only one microsatellite marker, and for the other two polyps the mobilities were different for more than two markers. These two polyps were obtained from one patient with ascending colon carcinoma and suspected HNPCC based on his clinical profile and family history. An RII mutation was detected in only one of these two polyps. RII may play a minor role in sporadic colorectal polyps. RII gene analysis in colorectal polyps may be a useful screening measure for potential HNPCC patients.
引用
收藏
页码:1803 / 1809
页数:7
相关论文
共 50 条
  • [21] Mutation of type II transforming growth factor beta receptor gene is uncommon in sporadic colorectal cancer and independent of loss of heterozygosity.
    Nakamori, S
    Shimada, M
    Tamura, S
    Kameyama, M
    Yasuda, T
    Hiratsuka, M
    Kabuto, T
    Furukawa, H
    Imaoka, S
    GASTROENTEROLOGY, 1997, 112 (04) : A624 - A624
  • [22] Reduction in transforming growth factor-β type II receptor in mouse lung carcinogenesis
    Jakowlew, SB
    Moody, TW
    You, L
    Mariano, JM
    MOLECULAR CARCINOGENESIS, 1998, 22 (01) : 46 - 56
  • [23] Control of type II transforming growth factor-β receptor expression by integrin ligation
    Wang, DH
    Sun, LZ
    Zborowska, E
    Willson, JKV
    Gong, JG
    Verraraghavan, J
    Brattain, MG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (18) : 12840 - 12847
  • [24] Deleting Transforming Growth Factor-β type II receptor increases renal fibrosis
    Gewin, L. S.
    Zent, R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 480 - 480
  • [25] Heterozygous mice for the transforming growth factor-β type II receptor gene have increased susceptibility to hepatocellular carcinogenesis
    Im, YH
    Kim, HT
    Kim, IY
    Factor, VM
    Hahm, KB
    Anzano, M
    Jang, JJ
    Flanders, K
    Haines, DC
    Thorgeirsson, SS
    Sizeland, A
    Kim, SJ
    CANCER RESEARCH, 2001, 61 (18) : 6665 - 6668
  • [26] Transcriptional activation of the type II transforming growth factor-β receptor gene upon differentiation of embryonal carcinoma cells
    Kelly, D
    Kim, SJ
    Rizzino, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (33) : 21115 - 21124
  • [27] Lack of transforming growth factor-β type II receptor expression in human retinoblastoma cells
    Horie, K
    Yamashita, H
    Mogi, A
    Takenoshita, S
    Miyazono, K
    JOURNAL OF CELLULAR PHYSIOLOGY, 1998, 175 (03) : 305 - 313
  • [28] Relation of type II transforming growth factor-β receptor to hepatic fibrosis and hepatocellular carcinoma
    Ueno, T
    Hashimoto, O
    Kimura, R
    Torimura, T
    Kawaguchi, T
    Nakamura, T
    Sakata, R
    Koga, H
    Sata, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 18 (01) : 49 - 55
  • [29] Methylation silencing of transforming growth factor-β receptor type II in rat prostate cancers
    Yamashita, Satoshi
    Takahashi, Satoru
    McDonell, Nathalie
    Watanabe, Naoko
    Niwa, Tohru
    Hosoya, Kosuke
    Tsujino, Yoshimi
    Shirai, Tomoyuki
    Ushijima, Toshikazu
    CANCER RESEARCH, 2008, 68 (07) : 2112 - 2121
  • [30] Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in sporadic colorectal cancer
    Shimada, M
    Nakamori, S
    Kameyama, M
    Furukawa, H
    Imaoka, S
    Iwanaga, T
    RECENT ADVANCES IN GASTROENTEROLOGICAL CARCINOGENESIS I, 1996, : 1025 - 1028